Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director departure
Pacira BioSciences, Inc. (PCRX) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/11/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/11/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/11/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/11/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/11/2023 3 Form 3 - Initial statement of beneficial ownership of securities:
10/11/2023 3 Form 3 - Initial statement of beneficial ownership of securities:
10/11/2023 3 Form 3 - Initial statement of beneficial ownership of securities:
10/11/2023 3 Form 3 - Initial statement of beneficial ownership of securities:
10/10/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Pacira BioSciences Appoints Four New Independent Directors to its Board of Directors"
09/26/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "TRANSITION AND RETIREMENT AGREEMENT",
"Pacira BioSciences Announces Leadership Succession Plan David Stack to Retire as Chairman and CEO Once Successor is Appointed Board Has Initiated Search for Successor"
08/04/2023 4 WINSTON ROY (Chief Medical Officer) has filed a Form 4 on Pacira BioSciences, Inc.
Txns: Sold 509 shares @ $34.875, valued at $17.8k
08/02/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
08/02/2023 144 Form 144 - Report of proposed sale of securities:
08/02/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/02/2023 8-K Quarterly results
07/07/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/05/2023 144 Form 144 - Report of proposed sale of securities:
06/16/2023 4 WINSTON ROY (Chief Medical Officer) has filed a Form 4 on Pacira BioSciences, Inc.
Txns: Granted 10,950 shares @ $0
Granted 27,500 options to buy @ $38.74, valued at $1.1M
06/16/2023 4 Williams Kristen Marie (Chief Administrative Officer) has filed a Form 4 on Pacira BioSciences, Inc.
Txns: Granted 10,950 shares @ $0
Sold 6,467 shares @ $37.03, valued at $239.5k
Granted 27,500 options to buy @ $38.74, valued at $1.1M
06/16/2023 4 STACK DAVID M (CEO and Chairman) has filed a Form 4 on Pacira BioSciences, Inc.
Txns: Granted 32,700 shares @ $0
Granted 245,400 options to buy @ $38.74, valued at $9.5M
06/16/2023 4 Riker Lauren Bullaro (Senior Vice President, Finance) has filed a Form 4 on Pacira BioSciences, Inc.
Txns: Granted 10,000 shares @ $0
Sold 586 shares @ $37.47, valued at $22k
Sold 5,773 shares @ $38.52, valued at $222.4k
Sold 7 shares @ $39.01, valued at $273.1
Granted 25,000 options to buy @ $38.74, valued at $968.5k
06/16/2023 4 Reinhart Charles A. III (CFO) has filed a Form 4 on Pacira BioSciences, Inc.
Txns: Granted 9,000 shares @ $0
Granted 22,500 options to buy @ $38.74, valued at $871.7k
06/16/2023 4 PACE GARY W (Director) has filed a Form 4 on Pacira BioSciences, Inc.
Txns: Granted 1,775 shares @ $0
Granted 12,925 options to buy @ $38.74, valued at $500.7k
06/16/2023 4 Kronenfeld Mark A. (Director) has filed a Form 4 on Pacira BioSciences, Inc.
Txns: Granted 1,775 shares @ $0
Granted 12,925 options to buy @ $38.74, valued at $500.7k
06/16/2023 4 HASTINGS PAUL J (Director) has filed a Form 4 on Pacira BioSciences, Inc.
Txns: Granted 1,775 shares @ $0
Granted 12,925 options to buy @ $38.74, valued at $500.7k
06/16/2023 4 GAUGLER DARYL (COO) has filed a Form 4 on Pacira BioSciences, Inc.
Txns: Granted 10,000 shares @ $0
Granted 25,000 options to buy @ $38.74, valued at $968.5k
06/16/2023 4 Froimson Mark (Director) has filed a Form 4 on Pacira BioSciences, Inc.
Txns: Granted 1,775 shares @ $0
Granted 12,925 options to buy @ $38.74, valued at $500.7k
06/16/2023 4 CHRISTIE CHRISTOPHER (Director) has filed a Form 4 on Pacira BioSciences, Inc.
Txns: Granted 1,775 shares @ $0
Granted 12,925 options to buy @ $38.74, valued at $500.7k
06/16/2023 4 Brege Laura (Director) has filed a Form 4 on Pacira BioSciences, Inc.
Txns: Granted 1,775 shares @ $0
Granted 12,925 options to buy @ $38.74, valued at $500.7k
06/12/2023 4 Kronenfeld Mark A. (Director) has filed a Form 4 on Pacira BioSciences, Inc.
Txns: Sold 15,000 shares @ $37.04, valued at $555.6k
Exercised 15,000 options to buy @ $29.9, valued at $448.5k
06/12/2023 144 Form 144 - Report of proposed sale of securities:
06/08/2023 144 Form 144 - Report of proposed sale of securities:
06/07/2023 4 WINSTON ROY (Chief Medical Officer) has filed a Form 4 on Pacira BioSciences, Inc.
Txns: Sold 1,779 shares @ $38.991, valued at $69.4k
Sold 1,857 shares @ $37.865, valued at $70.3k
06/07/2023 4 Williams Kristen Marie (Chief Administrative Officer) has filed a Form 4 on Pacira BioSciences, Inc.
Txns: Sold 1,301 shares @ $38.991, valued at $50.7k
Sold 1,357 shares @ $37.865, valued at $51.4k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy